Dublin, Feb. 01, 2017 -- Research and Markets has announced the addition of the "Global Orthopedic Biomaterials Market - By Type, By Sub-Type, By Application: Analysis By Region, By Country (2011-2021)" report to their offering.
Global Orthopaedic Biomaterial Market is forecasted to grow at a CAGR of 13.19% during 2016-2021.
Due to growing problem of osteoarthritis, bone preservation, less healing time and technological advancement like minimally invasive surgeries has led to an increase in the orthopaedic biomaterial market.
Growing demand for biodegradable and biocompatible product is increasing surging prevalence of Arthritis, Bone degeneration, Obesity and Diabetes among geriatric population. Also, the inclination of young population towards adapting such products has been driving the market.
Global Orthopaedic Biomaterial Market is forecasted to grow at a CAGR of 13.19 % during 2016-2021F, driven by rising clinical education among the patients, increasing medical applications of biomaterial by orthopaedicians, rising demand from the aged population, and technological innovation has further led to growing focus towards healthcare, hence, building the need for joint replacement surgeries using orthopaedic biomaterial, specifically among the adult population.
While the market has witnessed strong foothold in the regions of North America and Europe, however rapid growth is expected to be driven by the emerging nations in Asia Pacific and ROW.
The report provides coverage by Material Type, Metal Sub Type, Non-Metal Sub Type and By Application:
By Material Type
- Metal Orthopaedic Biomaterial
- Non-Metal Orthopaedic Biomaterial
By Metal Type
- Stainless Steel
- Titanium Alloys
- Cobalt-Chromium Alloys
- Others
By Non-Metal Type
- Polymer
- Ceramic
- Composite
By Polymer Type
- UHMWPE
- PEEK
- Fiber Reinforced Polymers
- Others
By Ceramic Type
- Bioinert Ceramic
- Bioactive Ceramics
By Composite Type
- PMMA
- Others
By Application
- Joint Replacement
- Spine Implant
- Oestosynthesis
- Orthobilogics
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
4. Global Orthopaedic Biomaterials Market
5. Global Orthopaedic Biomaterials Market: By Material Type (Metals and Non Metals)
6. Global Metal Orthopaedic Biomaterials Market: By Sub Type (Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys, Others)
7. Global Non-Metal Orthopaedic Biomaterials Market: By Sub Type (Polymer, Ceramic and Composites)
8. Global Polymer Orthopaedic Biomaterials Market
9. Global Ceramics Orthopaedic Biomaterial Market
10. Global Composite Orthopaedic Biomaterial Market
11. Global Orthopaedic Biomaterial Market: By Application (Joint Replacement, Spine Implant, Osteosynthesis, Orthobiologics)
12. Global Orthopaedic Biomaterial Market: By Regional Breakdown
13. North America Orthopaedic Biomaterial Market: Growth and Forecast
14. North America Orthopaedic Biomaterials Market: Country Analysis
15. Europe Orthopaedic Biomaterial Market: Growth and Forecast
16. Europe Orthopaedic Biomaterials Market: Country Analysis
17. APAC Orthopaedic Biomaterial Market: Growth and Forecast
18. APAC Orthopaedic Biomaterials Market: Country Analysis
19. ROW Orthopaedic Biomaterial Market: Growth and Forecast
20. ROW Orthopaedic Biomaterials Market: Country Analysis
21. Market Dynamics
22. Market Trends
23. SWOT Analysis - Orthopaedic Biomaterial Market
24. Porter's Five Forces Analysis - Orthopaedic Biomaterial Market
25. Policy and Regulatory Landscape
Company Profiling
- Acumed
- Amedica Corporation
- Exactech Inc.
- Globus Medical
- Johnson & Johnson
- Koninklijke DSM N.V.
- Medtronic PLC
- Stryker Corporation
- Wright Medical Group
- Zimmer Biomet Holdings Inc.
For more information about this report visit http://www.researchandmarkets.com/research/8qj47j/global_orthopedic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



